Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
RominaM. Bianchini, PatriciaM. Castellano & TeodoroS. Kaufman. (2012) STRESS TESTING OF VALSARTAN. DEVELOPMENT AND VALIDATION OF A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY STABILITY-INDICATING ASSAY. Journal of Liquid Chromatography & Related Technologies 35:8, pages 1053-1069.
Read now
Read now
NasrY. Khalil, TanveerA. Wani, MohamedA. Abunassif & IbrahimA. Darwish. (2011) SENSITIVE HPLC METHOD WITH FLUORESCENCE DETECTION AND ON-LINE WAVELENGTH SWITCHING FOR SIMULTANEOUS DETERMINATION OF VALSARTAN AND AMLODIPINE IN HUMAN PLASMA. Journal of Liquid Chromatography & Related Technologies 34:20, pages 2583-2595.
Read now
Read now
Artavazd Tadevosyan, Eric J MacLaughlin & Vardan T Karamyan. (2011) Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes. Patient Related Outcome Measures 2, pages 27-39.
Read now
Read now
Tomohiro Aoki & M Nishimura. (2010) Targeting chronic inflammation in cerebral aneurysms: focusing on NF-κB as a putative target of medical therapy. Expert Opinion on Therapeutic Targets 14:3, pages 265-273.
Read now
Read now
Bernard Waeber & Luis M Ruilope. (2009) Amlodipine and valsartan as components of a rational and effective fixed-dose combination. Vascular Health and Risk Management 5, pages 165-174.
Read now
Read now
John M Flack & Robert Hilkert. (2009) Single-pill combination of amlodipine and valsartan in the management of hypertension. Expert Opinion on Pharmacotherapy 10:12, pages 1979-1994.
Read now
Read now
Articles from other publishers (25)
Timon Kurzawa, Salim Fazzani, René Tempel, Hannes Helmboldt, Christian Bleschke, Andreas Kohlmann & Adelheid Hagenbach. (2023) Characterization of hitherto unknown Valsartan photodegradation impurities. Journal of Molecular Structure 1275, pages 134599.
Crossref
Crossref
Lin Chen, Li Ge, Qinghui Liang, Zhenbo Zhao & Kedi Yang. (2022) Eutectic solvents formed by (+)-DTTA and L-menthol as novel chiral recognition and separation media for enantioselective extraction of valsartan enantiomers. Journal of Molecular Liquids 368, pages 120818.
Crossref
Crossref
Yi Zhu, Li Ge, Lin Chen, Chen Chen, Yidan Wang & Kedi Yang. (2022) An efficient process for recycle S-valsartan from the racemic coproduct via diastereomeric crystallization by using natural dehydroabietylamine as the enantioselective recognition media. Separation and Purification Technology 282, pages 120056.
Crossref
Crossref
Wafa’ J. Aabed, Asma H. Radwan, Abdel Naser Zaid & Naser Y. Shraim. (2021) Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension. International Journal of Hypertension 2021, pages 1-10.
Crossref
Crossref
Maya S. Eissa & Amal M. Abou Al Alamein. (2018) Innovative spectrophotometric methods for simultaneous estimation of the novel two-drug combination: Sacubitril/Valsartan through two manipulation approaches and a comparative statistical study. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 193, pages 365-374.
Crossref
Crossref
Bahia A. Moussa, Hanaa M. A. Hashem, Marianne A. Mahrouse & Sally T. Mahmoud. (2017) Experimental Design Approach in HPLC Method Development: Application for the Simultaneous Determination of Sacubitril and Valsartan in Presence of Their Impurities and Investigation of Degradation Kinetics. Chromatographia 81:1, pages 139-156.
Crossref
Crossref
Raja Haranadha Babu Chunduri & Gowri Sankar Dannana. (2016) Development and validation of a reliable and rapid LC-MS/MS method for simultaneous quantification of sacubitril and valsartan in rat plasma and its application to a pharmacokinetic study. Biomedical Chromatography 30:9, pages 1467-1475.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
338
340
.
Jian-Rong Wang, Xiaojuan Wang, Liye Lu & Xuefeng Mei. (2013) Highly Crystalline Forms of Valsartan with Superior Physicochemical Stability. Crystal Growth & Design 13:7, pages 3261-3269.
Crossref
Crossref
Mohsen A. Hedaya & Sally A. Helmy. (2013) Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, 4-Period Crossover Study in Healthy Egyptian Male Volunteers. Clinical Therapeutics 35:6, pages 846-861.
Crossref
Crossref
Romina M. Bianchini, Patricia M. Castellano & Teodoro S. Kaufman. (2011) Characterization of two new potential impurities of Valsartan obtained under photodegradation stress condition. Journal of Pharmaceutical and Biomedical Analysis 56:1, pages 16-22.
Crossref
Crossref
Donald J. AbrahamRandy L. Webb & Gary M. Ksander. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
515
566
.
Howida Kamal Ibrahim & Doaa A. El-Setouhy. (2010) Valsartan Orodispersible Tablets: Formulation, In vitro/In vivo Characterization. AAPS PharmSciTech 11:1, pages 189-196.
Crossref
Crossref
Richard F. Hamman & Dana Dabelea. 2010. The Evidence Base for Diabetes Care. The Evidence Base for Diabetes Care
49
110
.
Emma D. Deeks. (2009) Amlodipine/Valsartan/Hydrochlorothiazide. American Journal Cardiovascular Drugs 9:6, pages 411-418.
Crossref
Crossref
Ana Cristina Franco Spínola, Susana Almeida, Augusto Filipe, Rita Neves, Fethi Trabelsi & Anna Farré. (2009) Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Clinical Therapeutics 31:9, pages 1992-2001.
Crossref
Crossref
Jeffrey Blumer, Donald L. Batisky, Thomas Wells, Victor Shi, Susan Solar-Yohay & Gangadhar Sunkara. (2009) Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects With Hypertension. The Journal of Clinical Pharmacology 49:2, pages 235-241.
Crossref
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs
1
196
.
Greg L Plosker & Dean M Robinson. (2008) Amlodipine/Valsartan. Drugs 68:3, pages 373-381.
Crossref
Crossref
Hao Li, Yingwu Wang, Yao Jiang, Yunbiao Tang, Jiang Wang, Limei Zhao & Jingkai Gu. (2007) A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. Journal of Chromatography B 852:1-2, pages 436-442.
Crossref
Crossref
G Neil Thomas, Paul Chan & Brian Tomlinson. (2006) The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension. Drugs & Aging 23:2, pages 131-155.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
3593
.
Noriko Daneshtalab, Richard Z. Lewanczuk, Anthony Russell & Fakhreddin Jamali. (2004) Rheumatoid Arthritis Does Not Reduce the Pharmacodynamic Response to Valsartan. The Journal of Clinical Pharmacology 44:3, pages 245-252.
Crossref
Crossref
JENNIFER MARTIN & HENRY KRUM. (2002) ROLE OF VALSARTAN AND OTHER ANGIOTENSIN RECEPTOR BLOCKING AGENTS IN THE MANAGEMENT OF CARDIOVASCULAR DISEASE. Pharmacological Research 46:3, pages 203-212.
Crossref
Crossref
Sevgi Tatar & Serap Sağlık. (2002) Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. Journal of Pharmaceutical and Biomedical Analysis 30:2, pages 371-375.
Crossref
Crossref